Diversity & Inclusion

Celebrating LGBTQIA+ Mental Health Trailblazers

Jun 14, 2022 12:10 PM ET
Campaign: Alkermes: Diversity, Inclusion & Belonging
Text: "Celebrating LGBTQIA+ Mental Health Trailblazers, swipe to learn more"
Image of Frank Kameny with text: Astronomer-turned-civil rights pioneer who played a crucial role in persuading the American Psychiatric Association to delist same-sex attraction as a mental disorder.
Photo of Kay Lahusen with text: "Famed photographer who documented the historical movement against anti-LGBTQIA+ conversion therapy."
Photo of Dr. Richard Isay with text: "A psychiatrist and gay rights activist, Dr. Isay led the charge in convincing the American Psychiatric Association to treat providers the same regardless of their sexuality and to promote LGBTQIA+ research within the network."

Pride Month is a time for us to celebrate the important strides made to support and advance LGBTQIA+ mental health. See the images to learn about several queer mental health trailblazers and keep up with us as we share resources all month long.

About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes logo